Evidence is lackingBMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c1613 (Published 26 March 2010) Cite this as: BMJ 2010;340:c1613
- Peter D Burrill, specialist pharmaceutical adviser for public health
- 1NHS Derbyshire County, Chesterfield S41 7PF
Sever states: “The evidence supports such use in those with an estimated 10 year risk of a cardiovascular event of >20%.”1 I am not aware of any prospective, placebo controlled randomised controlled trial (RCT) designed to test this hypothesis. A recent British Hypertension Society publication references a subgroup analysis of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial